Export 2751 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
A. Al-Uzri, Stablein, D. M., and Cohn, R. A., “Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, Transplantation, vol. 72, no. 6, pp. 1020-4, 2001.
A. Al-Uzri, Stablein, D. M., and Cohn, R., “Post-transplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Transplantation, vol. 72, pp. 1020-4, 2001.
R. Alejandro, Barton, F., Hering, B., Rickels, M., Berney, T., Pattou, F., Shapiro, A., and Investigators, C. I. T. R., “Predictiveness of Positive C-peptide for Outcomes of Islet Transplantation”, Xenotransplantation, vol. 16, pp. 286–329, 2009.
R. Alejandro, Barton, F. B., Hering, B. J., and Wease, S., “2008 Update from the Collaborative Islet Transplant Registry.”, Transplantation, vol. 86, no. 12, pp. 1783-8, 2008.
R. Alejandro, Barton, F., Hering, B., Rickels, M., Berney, T., Pattou, F., Secchi, A., Shapiro, A., and Investigators, T. Collaborat, “Improvement in Outcomes of Islet Transplantation: CITR 1999-2008”, Xenotransplantation, vol. 16, pp. 286-329, 2009.
R. Alejandro, Barton, F. B., Hering, B. J., Wease, S., and Investigators, C. Islet Tran, “2008 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry”, in The Transplantation Society Annual Meeting, Sydney Australia, 2008, 2Snd ed., vol. 86.
R. Alejandro, Barton, F. B., Hering, B. J., Wease, S., and Investigators, C. Islet Tran, “2008 Update from the Collaborative Islet Transplant Registry”, Transplantation, vol. 86, pp. 1783-1788, 2008.
J. W. Alexander, Metze, T. J., McIntosh, M. J., Goodman, H. R., First, M. R., Munda, R., Cardi, M. A., Austin, J. N., Goel, S., Safdar, S., Greenberg, N., Chen, X., and Woodle, E. S., “The Influence of Immunomodulatory Diets on Transplant Success and Complications”, Transplantation, vol. 79, pp. 460-465, 2005.
J. W. Alexander, Light, J. A., Donaldson, L. A., Delmonico, F. L., Diethelm, A. G., Wilkinson, A., Rosenthal, J. T., Thistlethwaite, J. R., Hunsicker, L. G., Matas, A. J., First, M. R., Reinsmoen, N. L., and Rose, S. M., “Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.”, Transplantation, vol. 68, no. 8, pp. 1117-24, 1999.
J. Alexander, Light, J., Donaldson, L., Delmonico, F., Diethelm, A., Wilkinson, A., Thistlethwaite, J., Hunsicker, L., Matas, J., Reinsmoen, N., and Rose, S., “Evaluation of pre- and post-transplant DST/CsA in non-HLA identical living donor kidney transplant recipients”, Transplantation, vol. 68, pp. 1117-24, 1999.
J. Alexander, Metze, T., Goodman, H., McIntosh, M., Zeng, L., Cardi, M., Austin, J., Goel, S., Safdar, S., Greenburg, N., and Woodle, E., “Transplant Success and Immunodulating Diets”, 2003.
W. J Alexander, Metze, T. J., McIntosh, M. J., Goodman, H. R., M First, R., Munda, R., Cardi, M. A., Austin, J. N., Goel, S., Safdar, S., Greenberg, N., Chen, X., and E Woodle, S., “The influence of immunomodulatory diets on transplant success and complications.”, Transplantation, vol. 79, no. 4, pp. 460-5, 2005.
M. Allen, Israel, H., Rybczyk, K., Pugliese, M. A., Loughran, K., Wagner, L., and Erb, S., “Trial-related discrimination in HIV vaccine clinical trials.”, AIDS Res Hum Retroviruses, vol. 17, no. 8, pp. 667-74, 2001.
C. E. Allen, Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., Hanna, R., Burroughs, L., Kean, L., Talano, J. - A., Schultz, K. R., Pai, S. - Y., K Baker, S., Andolina, J. R., Stenger, E. O., Connelly, J., Ramirez, A., Bryant, C., Eapen, M., and Pulsipher, M. A., “Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.”, Blood, vol. 132, no. 13, pp. 1438-1451, 2018.
C. A. Allen, Yesko, L., and Van Veldhuisen, P., “Implications of Modifying Study Eligibility Criteria Post-Initiation of Recruitment”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
M. A. Allen, Israel, H. A., Rybczyk, K., Pugliese, M., Loughran, K., Wagner, L., and Erb, S., “Trial-related discrimination in HIV vaccine clinical trials”, AIDS Res HumRetroviruses, vol. 17, pp. 667-74, 2001.
H. Allewelt, El-Khorazaty, J., Mendizabal, A., Taskindoust, M., Martin, P. L., Prasad, V., Page, K., Sanders, J., and Kurtzberg, J., “Late Effects after Umbilical Cord Blood Transplantation in Very Young Children after Busulfan-Based, Myeloablative Conditioning.”, Biol Blood Marrow Transplant, vol. 22, no. 9, pp. 1627-1635, 2016.
E. M. Alonso, Limbers, C. A., Neighbors, K., Martz, K., Bucuvalas, J. C., Webb, T., and Varni, J. W., “Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients.”, J Pediatr, vol. 156, no. 2, pp. 270-6.e1, 2010.
E. M. Alonso, Martz, K., Wang, D., Yi, M. S., Neighbors, K., Varni, J. W., Bucuvalas, J. C., and FOG), T. Studies of, “Factors Predicting Health Related Quality of Life in Pediatric Liver Transplant Recipients in the Functional Outcomes Group”, Pediatr Transplant, vol. 17, pp. 605-611, 2013.
E. M. Alonso, Martz, K., Wang, D., Yi, M. S., Neighbors, K., Varni, J. W., and Bucuvalas, J. C., “Factors predicting health-related quality of life in pediatric liver transplant recipients in the functional outcomes group.”, Pediatr Transplant, vol. 17, no. 7, pp. 605-11, 2013.
E. M. Alonso, Shepherd, R., Martz, K. L., Yin, W., and Anand, R., “Linear growth patterns in prepubertal children following liver transplantation.”, Am J Transplant, vol. 9, no. 6, pp. 1389-97, 2009.
E. Alonso and Anand, R., “Studies of pediatric liver transplantation. School attendance and growth of school age children following liver transplantation”, Transplantation, vol. 69, p. S307, 2000.
E. Alonso, Limbers, C., Neighbors, K., Martz, K., Bucuvalas, J., Webb, T., Varni, J., and FOG), Sof Pediatr, “Cross-sectional Analysis of Health Related Quality of Life in Pediatric Liver Transplant Recipients”, J Pediatr, vol. 156, pp. 270-276.e271, 2010.
A. M. Alousi, Weisdorf, D. J., Logan, B. R., Bolaños-Meade, J., Carter, S., DiFronzo, N., Pasquini, M., Goldstein, S. C., Ho, V. T., Hayes-Lattin, B., Wingard, J. R., Horowitz, M. M., and Levine, J. E., “Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.”, Blood, vol. 114, no. 3, pp. 511-7, 2009.
A. Alousi, Weisdorf, D., Logan, B., Bolanos-Meade, J., Carter, S., DiFronzo, N., Pasquini, M., Goldstein, S., Ho, V., Hayes-Lattin, B., Wingard, J., Horowitz, M., and Levine, J., “Etanercept, Mycophenolate, Denileukin, or Pentostatin Plus Corticosteroids for Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial from the Blood and Marrow Transplant Clinical Trials Network”, Blood, vol. 114, pp. 511-517, 2009.